Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy

JAMA Intern Med. 2013 Oct 14;173(18):1746-8. doi: 10.1001/jamainternmed.2013.9329.
No abstract available

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-Retroviral Agents / economics
  • Anti-Retroviral Agents / therapeutic use*
  • CD4 Lymphocyte Count / economics
  • Cost Savings
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / economics*
  • HIV Infections / epidemiology
  • Humans
  • Male
  • Monitoring, Physiologic / economics*
  • Morbidity / trends
  • United States / epidemiology
  • Young Adult

Substances

  • Anti-Retroviral Agents